NASDAQ · Healthcare · Medical - Instruments & Supplies
Embecta Corp.
EMBC
Embecta Corp. CEO Devdatt Kurdikar · Market cap $310.3M.
$5.23
-0.24 · -4.39%
52w hi $15.5552w lo $2.77
Off 52w high 67.1%
80
STRONG
Current InsiderScore
Corp · 90d
4
4 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
4
2 strong · 2 notable
Analyst consensus
Hold
Avg PT $5.00
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 12 | Robert J. Hombach | Buy | 45,000 | $4.97 | +$224K | 80 | |
| Aug 12 | Jeffrey Z Mann | Pres, Pharm Svc&Prod Mgmt, CLO | Buy | 20,000 | $4.99 | +$100K | 69 |
| Aug 12 | Devdatt Kurdikar | President and CEO | Buy | 30,000 | $4.70 | +$141K | 76 |
| Aug 12 | Jacob Elguicze | SVP and CFO | Buy | 20,000 | $4.67 | +$93K | 73 |
| May 23 | David F Melcher | Buy | 10,000 | $10.60 | +$106K | 56 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug